WO2001094362A3 - Haplotypes du gene acp2 - Google Patents

Haplotypes du gene acp2 Download PDF

Info

Publication number
WO2001094362A3
WO2001094362A3 PCT/US2001/018457 US0118457W WO0194362A3 WO 2001094362 A3 WO2001094362 A3 WO 2001094362A3 US 0118457 W US0118457 W US 0118457W WO 0194362 A3 WO0194362 A3 WO 0194362A3
Authority
WO
WIPO (PCT)
Prior art keywords
acp2
gene
haplotypes
disclosed
haplotyping
Prior art date
Application number
PCT/US2001/018457
Other languages
English (en)
Other versions
WO2001094362A2 (fr
Inventor
Stefanie E Kliem
Chad Messer
Debra A Tanguay
Original Assignee
Genaissance Pharmaceuticals
Stefanie E Kliem
Chad Messer
Debra A Tanguay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Stefanie E Kliem, Chad Messer, Debra A Tanguay filed Critical Genaissance Pharmaceuticals
Priority to AU2001266759A priority Critical patent/AU2001266759A1/en
Publication of WO2001094362A2 publication Critical patent/WO2001094362A2/fr
Publication of WO2001094362A3 publication Critical patent/WO2001094362A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

La présente invention concerne de nouveaux variants génétiques du gène lysosomal de la phosphatase acide 2 (ACP2). L'invention se rapporte à divers génotypes, haplotypes et paires d'haplotypes du gène ACP2 qui existent dans la population générale des Etats-Unis. L'invention concerne aussi des compositions et des procédés permettant l'haplotypage et/ou le génotypage du gène ACP2 chez un individu. L'invention concerne enfin des polynucléotides définis par la séquence des haplotypes précités.
PCT/US2001/018457 2000-06-07 2001-06-07 Haplotypes du gene acp2 WO2001094362A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001266759A AU2001266759A1 (en) 2000-06-07 2001-06-07 Haplotypes of the acp2 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21004700P 2000-06-07 2000-06-07
US60/210,047 2000-06-07

Publications (2)

Publication Number Publication Date
WO2001094362A2 WO2001094362A2 (fr) 2001-12-13
WO2001094362A3 true WO2001094362A3 (fr) 2002-06-13

Family

ID=22781388

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/018457 WO2001094362A2 (fr) 2000-06-07 2001-06-07 Haplotypes du gene acp2

Country Status (2)

Country Link
AU (1) AU2001266759A1 (fr)
WO (1) WO2001094362A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1775590A1 (fr) * 2005-10-11 2007-04-18 Laboratorios S.A.L.V.A.T., S.A. Procédé non invasif pour la détection in vitro du carcinome transitionnel de la vessie

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GEIER C. ET AL.: "Structure of the human lysosomal phosphatase gene", EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 183, 1989, pages 611 - 616, XP002906605 *

Also Published As

Publication number Publication date
AU2001266759A1 (en) 2001-12-17
WO2001094362A2 (fr) 2001-12-13

Similar Documents

Publication Publication Date Title
WO2001090122A3 (fr) Haplotypes du gene ctla4
WO2002006294A3 (fr) Haplotypes du gene mmp13
WO2001079234A3 (fr) Haplotypes du gene apoe
WO2001094362A3 (fr) Haplotypes du gene acp2
WO2002018414A3 (fr) Haplotypes du gène bf
WO2002010454A3 (fr) Haplotypes du gene alas2? ¿
WO2002012499A3 (fr) Haplotypes du gene ntf3
WO2001092278A3 (fr) Haplotypes du gene rlbp1
WO2002030950A3 (fr) Haplotypes du gene fy
WO2001087909A3 (fr) Haplotypes du gene aanat
WO2002002580A3 (fr) Haplotypes du gene etfb
WO2001090127A3 (fr) Haplotypes du gene de hoxd3
WO2001087907A3 (fr) Haplotypes du gene de l'osm
WO2002012562A3 (fr) Haplotypes du gene pla2g1b
WO2002040502A3 (fr) Haplotypes du gene de la lipase hormono-sensible
WO2002090378A3 (fr) Haplotypes du gene de ces2
WO2002016399A3 (fr) Haplotypes du gene tacr1
WO2001090118A3 (fr) Haplotypes du gene edn2
WO2002050098A3 (fr) Haplotypes du gene du recepteur de la prolactine (prlr)
WO2002094850A3 (fr) Haplotypes du gene gnrh2
WO2002038586A3 (fr) Haplotypes du gene il6
WO2002029089A3 (fr) Haplotypes du gene d'htatip
WO2002055534A3 (fr) Haplotypes du gene f2rli
WO2001092279A3 (fr) Haplotypes du gene aldh5
WO2002032924A3 (fr) Haplotypes du gene chrm5

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WPC Withdrawal of priority claims after completion of the technical preparations for international publication

Ref country code: WO

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP